Charming Medical Limited Faces Class Action
Analysis based on 13 articles · First reported Jan 29, 2026 · Last updated Feb 09, 2026
The market is negatively impacted by the alleged fraudulent activities of Charming Medical Limited, leading to investor losses and a class action lawsuit. This event underscores the importance of regulatory oversight by the United States===United States Securities and Exchange Commission in maintaining market integrity.
The Schall Law Firm has filed a class action lawsuit against Charming Medical Limited for alleged violations of securities laws. The lawsuit claims that Charming Medical Limited made false and misleading statements, leading to an SEC trading suspension in November 2025. The suspension followed a dramatic spike in the company's share price, which was attributed to a promotion scheme involving supposed financial advisors touting the company on social media. Investors who purchased Charming Medical Limited securities between October 21, 2025, and November 12, 2025, are encouraged to join the lawsuit to recover their losses.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard